Status:
ENROLLING_BY_INVITATION
Infective Endocarditis Surgery Using Conventional Prosthetic Valves Versus Cryopreserved Aortic Homograft
Lead Sponsor:
Centre Cardiologique du Nord
Collaborating Sponsors:
Campus Bio-Medico University
Henri Mondor University Hospital
Conditions:
Infective Endocarditis
Heart Failure
Eligibility:
All Genders
18-90 years
Brief Summary
: Evidence suggested that autologous or allogeneic tissue is more suitable to synthetic material in an infected field. Given the unwillingness of some surgeons to use artificial foreign materials, suc...
Detailed Description
The target population enrolled in the study includes patients with aortic-valve endocarditis at risk of embolization, heart failure and uncontrolled infection undergoing AVR with the use of CAH or con...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Duke Criteria
- Uncontrolled Infection Local abscess Large vegetation False aneurysm, Fistula, Dehiscence of PV
- Embolism Large vegetation \>10mm, persistent infection
- Heart Failure Involvement of aortic root, intervalvular fibrosa, pulmonary edema, cardiogenic shock
- Exclusion Criteria :
- Pediatric
- Any echocardiographic evidence of absence of IE
Exclusion
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
760 Patients enrolled
Trial Details
Trial ID
NCT05253469
Start Date
January 1 2005
End Date
December 1 2026
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Francesco Nappi
Saint-Denis, France, 93200